1 FDA Grants Fast Track Designation to Lantern Pharma’s AI-Enhanced Drug LP-184 for Glioblastoma thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Clearmind Medicine Receives IRB Approval for Phase I/IIa Clinical Trial of CMND-100 Targeting Alcohol Use Disorder thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Relapsed or Refractory Metastatic Colorectal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Anti-Glomerular Basement Membrane (anti-GBM) Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 FDA Grants Breakthrough Therapy Designation to Mirum’s Volixibat for Cholestatic Pruritus in PBC thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Axial Spondyloarthritis (axSpA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Bazex-Dupre-Christol Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Epidermodysplasia Verruciformis (EV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 B-Acute Lymphocytic Leukemia (ALL) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Relapsed / Refractory B-Acute Lymphocytic Leukemia (ALL) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 1 year ago in Business 0